US Bancorp’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$117K Sell
387
-127
-25% -$38.4K ﹤0.01% 2348
2025
Q1
$170K Buy
514
+23
+5% +$7.62K ﹤0.01% 2093
2024
Q4
$152K Sell
491
-72
-13% -$22.2K ﹤0.01% 2176
2024
Q3
$119K Sell
563
-229
-29% -$48.6K ﹤0.01% 2305
2024
Q2
$222K Buy
792
+58
+8% +$16.2K ﹤0.01% 1946
2024
Q1
$196K Sell
734
-659
-47% -$176K ﹤0.01% 2020
2023
Q4
$322K Sell
1,393
-854
-38% -$198K ﹤0.01% 1753
2023
Q3
$328K Sell
2,247
-167
-7% -$24.4K ﹤0.01% 1589
2023
Q2
$558K Buy
2,414
+493
+26% +$114K ﹤0.01% 1330
2023
Q1
$465K Buy
1,921
+1,421
+284% +$344K ﹤0.01% 1433
2022
Q4
$145K Buy
500
+142
+40% +$41.2K ﹤0.01% 2027
2022
Q3
$23K Buy
358
+202
+129% +$13K ﹤0.01% 2945
2022
Q2
$11K Sell
156
-194
-55% -$13.7K ﹤0.01% 3323
2022
Q1
$34K Buy
350
+37
+12% +$3.59K ﹤0.01% 2801
2021
Q4
$27K Buy
313
+287
+1,104% +$24.8K ﹤0.01% 2944
2021
Q3
$2K Sell
26
-79
-75% -$6.08K ﹤0.01% 3856
2021
Q2
$10K Sell
105
-8
-7% -$762 ﹤0.01% 3377
2021
Q1
$13K Buy
113
+79
+232% +$9.09K ﹤0.01% 3181
2020
Q4
$4K Buy
34
+26
+325% +$3.06K ﹤0.01% 3426
2020
Q3
$1K Hold
8
﹤0.01% 3527
2020
Q2
$1K Sell
8
-228
-97% -$28.5K ﹤0.01% 3533
2020
Q1
$16K Buy
236
+8
+4% +$542 ﹤0.01% 2788
2019
Q4
$21K Sell
228
-31
-12% -$2.86K ﹤0.01% 2833
2019
Q3
$22K Buy
259
+228
+735% +$19.4K ﹤0.01% 2798
2019
Q2
$3K Hold
31
﹤0.01% 3384
2019
Q1
$4K Hold
31
﹤0.01% 3293
2018
Q4
$3K Sell
31
-67
-68% -$6.48K ﹤0.01% 3322
2018
Q3
$21K Buy
98
+47
+92% +$10.1K ﹤0.01% 2912
2018
Q2
$14K Buy
+51
New +$14K ﹤0.01% 3046
2015
Q3
Sell
-16
Closed -$1K 3637
2015
Q2
$1K Buy
+16
New +$1K ﹤0.01% 3494